Artelo Biosciences, Inc. (ARTL)Healthcare | Biotechnology | Solana Beach, United States | NasdaqCM
4.53 USD
+0.09
(1.914%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:47 a.m. EDT
High-conviction sell; despite recent fundraising and a reverse split, ARTL shows deteriorating fundamentals with negative cash flow, a broken balance sheet (cash < debt), and a technically collapsing stock price dropping ~49% in two weeks, indicating strong short-term bearish pressure and no long-term investment case. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.267141 |
| AutoETS | 0.272308 |
| AutoARIMA | 0.274346 |
| AutoTheta | 0.274933 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.99 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.160 |
| Excess Kurtosis | -1.04 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 4,245,052 |
| Forward P/E | -5.14 |
| Beta | 0.41 |
| Website | https://artelobio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.78328544 |
| Address1 | 505 Lomas Santa Fe |
| Address2 | Suite 160 |
| All Time High | 1,350.0 |
| All Time Low | 2.955 |
| Ask | 4.55 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 3,709,680 |
| Average Daily Volume3 Month | 3,419,896 |
| Average Volume | 3,419,896 |
| Average Volume10Days | 3,709,680 |
| Beta | 0.409 |
| Bid | 3.94 |
| Bid Size | 2 |
| Book Value | -1.89 |
| City | Solana Beach |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.525 |
| Current Ratio | 0.172 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 5.6399 |
| Day Low | 4.4801 |
| Display Name | Artelo Biosciences |
| Dividend Date | 1,561,075,200 |
| Earnings Timestamp End | 1,755,261,000 |
| Earnings Timestamp Start | 1,754,915,400 |
| Ebitda Margins | 0.0 |
| Enterprise Value | 3,282,863 |
| Eps Forward | -0.88 |
| Eps Trailing Twelve Months | -37.56 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.05842 |
| Fifty Day Average Change | -0.5334201 |
| Fifty Day Average Change Percent | -0.10545191 |
| Fifty Two Week Change Percent | -78.328545 |
| Fifty Two Week High | 85.8 |
| Fifty Two Week High Change | -81.275 |
| Fifty Two Week High Change Percent | -0.94726104 |
| Fifty Two Week Low | 2.955 |
| Fifty Two Week Low Change | 1.5700002 |
| Fifty Two Week Low Change Percent | 0.5313029 |
| Fifty Two Week Range | 2.955 - 85.8 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,561,123,800,000 |
| Float Shares | 644,698 |
| Forward Eps | -0.88 |
| Forward P E | -5.1420455 |
| Free Cashflow | -4,168,625 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 7 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10729 |
| Held Percent Institutions | 0.035 |
| Implied Shares Outstanding | 938,133 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,773,100,800 |
| Last Split Factor | 1:3 |
| Long Business Summary | Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. |
| Long Name | Artelo Biosciences, Inc. |
| Market | us_market |
| Market Cap | 4,245,052 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_274120655 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -12,879,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 4,268,505 |
| Open | 5.12 |
| Operating Cashflow | -8,520,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 858 925 7049 |
| Pre Market Change | -0.45499992 |
| Pre Market Change Percent | -10.055246 |
| Pre Market Price | 4.07 |
| Pre Market Time | 1,776,777,303 |
| Previous Close | 4.44 |
| Price Hint | 4 |
| Price To Book | -2.39418 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.148 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.085 |
| Regular Market Change Percent | 1.91442 |
| Regular Market Day High | 5.6399 |
| Regular Market Day Low | 4.4801 |
| Regular Market Day Range | 4.4801 - 5.6399 |
| Regular Market Open | 5.12 |
| Regular Market Previous Close | 4.44 |
| Regular Market Price | 4.525 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 32,664,314 |
| Return On Assets | -1.9009199 |
| Return On Equity | -16.2511 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 938,133 |
| Shares Percent Shares Out | 0.5787 |
| Shares Short | 472,907 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 17,715 |
| Short Name | Artelo Biosciences, Inc. |
| Short Percent Of Float | 0.5794 |
| Short Ratio | 0.06 |
| Source Interval | 15 |
| State | CA |
| Symbol | ARTL |
| Total Cash | 600,000 |
| Total Cash Per Share | 0.847 |
| Total Debt | 678,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -37.56 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 13.804455 |
| Two Hundred Day Average Change | -9.279455 |
| Two Hundred Day Average Change Percent | -0.6722073 |
| Type Disp | Equity |
| Volume | 32,664,314 |
| Website | https://artelobio.com |
| Zip | 92,075 |